Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387158082> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4387158082 endingPage "4541" @default.
- W4387158082 startingPage "4533" @default.
- W4387158082 abstract "Niraparib dosages can be individualized to reduce the starting dose based on body weight and baseline platelet count. However, even with individualized dosing, scattered cases of ≥Grade 3 hematologic toxicity occur. This study explored markers predictive of serious hematologic toxicity in niraparib therapy.This retrospective observational study investigated patients who started niraparib therapy at the Cancer Institute Hospital of the Japanese Foundation for Cancer Research between December 2020 and March 2022. Associations between hematologic toxicities and serum creatinine ratio (percentage increase in serum creatinine between baseline and after niraparib initiation) were investigated.Out of 50 ovarian cancer patients who initiated niraparib, 45 patients were included in the final analysis. Twenty-three patients (51.1%) developed ≥Grade 3 hematologic toxicity, with neutropenia in 17 (37.8%), anemia in 9 (20.0%), and thrombocytopenia in 4 (8.9%). Patients with Grade 4 hematologic toxicity showed higher serum creatinine ratios than those with ≤Grade 2. Thrombocytopenia ≥Grade 3 occurred only within 2 months of niraparib initiation and was preceded by an increase in serum creatinine in all affected patients.Serum creatinine ratio offers a potential marker for predicting severe hematologic toxicity following niraparib therapy." @default.
- W4387158082 created "2023-09-30" @default.
- W4387158082 creator A5002937982 @default.
- W4387158082 creator A5007258325 @default.
- W4387158082 creator A5007566552 @default.
- W4387158082 creator A5013666054 @default.
- W4387158082 creator A5025132856 @default.
- W4387158082 creator A5030047290 @default.
- W4387158082 creator A5041172182 @default.
- W4387158082 creator A5082336612 @default.
- W4387158082 creator A5083126575 @default.
- W4387158082 creator A5083554212 @default.
- W4387158082 creator A5084150828 @default.
- W4387158082 date "2023-09-29" @default.
- W4387158082 modified "2023-10-03" @default.
- W4387158082 title "Serum Creatinine Elevation as a Risk Factor for Niraparib-induced Hematologic Toxicity" @default.
- W4387158082 doi "https://doi.org/10.21873/anticanres.16647" @default.
- W4387158082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37772578" @default.
- W4387158082 hasPublicationYear "2023" @default.
- W4387158082 type Work @default.
- W4387158082 citedByCount "0" @default.
- W4387158082 crossrefType "journal-article" @default.
- W4387158082 hasAuthorship W4387158082A5002937982 @default.
- W4387158082 hasAuthorship W4387158082A5007258325 @default.
- W4387158082 hasAuthorship W4387158082A5007566552 @default.
- W4387158082 hasAuthorship W4387158082A5013666054 @default.
- W4387158082 hasAuthorship W4387158082A5025132856 @default.
- W4387158082 hasAuthorship W4387158082A5030047290 @default.
- W4387158082 hasAuthorship W4387158082A5041172182 @default.
- W4387158082 hasAuthorship W4387158082A5082336612 @default.
- W4387158082 hasAuthorship W4387158082A5083126575 @default.
- W4387158082 hasAuthorship W4387158082A5083554212 @default.
- W4387158082 hasAuthorship W4387158082A5084150828 @default.
- W4387158082 hasBestOaLocation W43871580821 @default.
- W4387158082 hasConcept C126322002 @default.
- W4387158082 hasConcept C141071460 @default.
- W4387158082 hasConcept C2777063308 @default.
- W4387158082 hasConcept C2778248108 @default.
- W4387158082 hasConcept C2780306776 @default.
- W4387158082 hasConcept C29730261 @default.
- W4387158082 hasConcept C71924100 @default.
- W4387158082 hasConcept C90924648 @default.
- W4387158082 hasConceptScore W4387158082C126322002 @default.
- W4387158082 hasConceptScore W4387158082C141071460 @default.
- W4387158082 hasConceptScore W4387158082C2777063308 @default.
- W4387158082 hasConceptScore W4387158082C2778248108 @default.
- W4387158082 hasConceptScore W4387158082C2780306776 @default.
- W4387158082 hasConceptScore W4387158082C29730261 @default.
- W4387158082 hasConceptScore W4387158082C71924100 @default.
- W4387158082 hasConceptScore W4387158082C90924648 @default.
- W4387158082 hasIssue "10" @default.
- W4387158082 hasLocation W43871580821 @default.
- W4387158082 hasLocation W43871580822 @default.
- W4387158082 hasOpenAccess W4387158082 @default.
- W4387158082 hasPrimaryLocation W43871580821 @default.
- W4387158082 hasRelatedWork W1586374228 @default.
- W4387158082 hasRelatedWork W2003938723 @default.
- W4387158082 hasRelatedWork W2047967234 @default.
- W4387158082 hasRelatedWork W2118496982 @default.
- W4387158082 hasRelatedWork W2364998975 @default.
- W4387158082 hasRelatedWork W2369162477 @default.
- W4387158082 hasRelatedWork W2439875401 @default.
- W4387158082 hasRelatedWork W2999158084 @default.
- W4387158082 hasRelatedWork W4238867864 @default.
- W4387158082 hasRelatedWork W2525756941 @default.
- W4387158082 hasVolume "43" @default.
- W4387158082 isParatext "false" @default.
- W4387158082 isRetracted "false" @default.
- W4387158082 workType "article" @default.